Verrica Sets Nov. 12 Earnings Call as Drug Pipeline Expands
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) will report its third-quarter 2026 financial results and provide an update on its dermatology drug development programs Thursday, Nov. 12, at …
Verrica Sets Nov. 12 Earnings Call as Drug Pipeline Expands Read More